STOCK TITAN

Seres Therapeutics, Inc. (MCRB) Revenue by Year

MCRB

Seres Therapeutics, Inc. generated $789K in revenue in fiscal year 2025. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Seres Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $789K
5Y CAGR -52.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MCRB Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Revenue$789K$0$0-100.0%$7.1M-95.1%$144.9M+336.3%$33.2M-3.7%$34.5M+22.1%$28.3M-11.9%$32.1M+47.5%$21.8M$0N/AN/A

MCRB Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$736K$358KN/A$351K$0$0N/A$0-100.0%$0-100.0%$0N/A$310K-91.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Seres Therapeutics, Inc. financials

Frequently Asked Questions

What was Seres Therapeutics, Inc.'s revenue in fiscal year 2025?

Seres Therapeutics, Inc. generated $789K in revenue in fiscal year 2025.

What was Seres Therapeutics, Inc.'s revenue in the most recent quarter?

Seres Therapeutics, Inc. (MCRB) reported $736K in revenue in Q2 2026.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Seres Therapeutics, Inc. (MCRB) reported on that line in every period on record.